Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,190 GBX | +1.35% | -0.86% | +15.00% |
May. 31 | Health Care Stocks Climb On Drug News -- Health Care Roundup | DJ |
May. 31 | Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal | MT |
Financials (USD)
Sales 2024 * | 51.62B | Sales 2025 * | 55.5B | Capitalization | 240B |
---|---|---|---|---|---|
Net income 2024 * | 8.84B | Net income 2025 * | 10.38B | EV / Sales 2024 * | 5.05 x |
Net Debt 2024 * | 20.42B | Net Debt 2025 * | 13.71B | EV / Sales 2025 * | 4.58 x |
P/E ratio 2024 * |
27.4
x | P/E ratio 2025 * |
23.3
x | Employees | 89,900 |
Yield 2024 * |
1.98% | Yield 2025 * |
2.09% | Free-Float | 96.62% |
Latest transcript on AstraZeneca PLC
1 day | +1.35% | ||
1 week | -0.86% | ||
1 month | +0.16% | ||
3 months | +20.93% | ||
6 months | +19.53% | ||
Current year | +15.00% |
Managers | Title | Age | Since |
---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 64 | 12-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 21-07-31 |
Cindy Hoots
CTO | Chief Tech/Sci/R&D Officer | 56 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 65 | 17-09-30 |
Ahmed Hamdy
PRN | Corporate Officer/Principal | 59 | 13-01-31 |
Philip Broadley
BRD | Director/Board Member | 63 | 17-04-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.20% | 11 M€ | +0.83% | - | |
5.39% | 200 M€ | +16.70% | ||
5.17% | 17 M€ | +6.09% | - | |
4.89% | 693 M€ | +12.25% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 12,190 | +1.35% | 4,183,291 |
24-05-30 | 12,028 | +0.82% | 1,694,794 |
24-05-29 | 11,930 | -0.81% | 2,028,915 |
24-05-28 | 12,028 | -2.18% | 2,196,897 |
24-05-24 | 12,296 | -0.87% | 919,468 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.00% | 240B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B | |
-.--% | 122B |
- Stock Market
- Equities
- AZN Stock